Thailand LRC Fertility Center IVF Cost Breakdown: Fee Items & Budget Planning Reference

AI Summary

Opening: Real Consultation Scenario

Last month, a 38-year-old client contacted me online. Her AMH level was 1.2, her husband's semen analysis was normal, and both partners' chromosome karyotypes showed no abnormalities. She planned to undergo PGT-A (3rd generation) IVF at Thailand LRC Fertility Center. Her primary concern was the cost — "Exactly how much money do I need to prepare? Will there be unexpected additional charges along the way? Are there any hidden fees?" This question is very typical, involving variables such as advanced age, diminished ovarian reserve, and the need for PGT-A. There is indeed no single answer for the cost, but it can be broken down into specific components, allowing for budgeting based on individual circumstances.

Module A: Direct Answer to the Question

LRC Fertility Center Cost Range Reference

Based on publicly available industry information and professional experience, the costs at Thailand LRC Fertility Center can be broadly categorized into two types according to the treatment path:

The above costs include core medical expenses but exclude living costs such as accommodation, transportation, and interpretation. Estimated living costs are approximately 30,000 to 50,000 RMB (based on a 25-30 day stay in Thailand).

Module K: Factors Influencing Cost

6 Key Variables Affecting the Final Cost

Even when undergoing PGT-A, the final cost for different individuals can vary by 50,000 to 80,000 RMB. The differences mainly arise from the following factors:

① Age and Ovarian Reserve

For individuals under 35 with AMH ≥ 2.0, the dosage of ovarian stimulation medication is relatively controllable, typically costing between 15,000 and 25,000 RMB. For those over 38 or with AMH < 1.0, higher doses or longer stimulation days may be required, potentially increasing medication costs to 30,000 to 45,000 RMB. A lower number of follicles can also affect the number of embryos, thereby influencing the billing method for PGT screening (charged per embryo).

② Choice of Ovarian Stimulation Medication Brand

There is a significant price difference between imported medications (e.g., Gonal-f, Puregon) and domestic ones (e.g., Lishenbao). Using exclusively imported medications can increase medication costs by approximately 8,000 to 12,000 RMB compared to domestic protocols. LRC allows patients to choose the medication brand based on their budget, with the doctor providing recommendations based on ovarian response.

③ Number of Embryos for PGT Screening

PGT screening is typically charged per embryo, costing approximately 4,000 to 7,000 RMB per embryo. Screening 5 embryos versus 10 embryos results in a cost difference of 20,000 to 35,000 RMB. The number of embryos requiring screening depends on the total number of eggs retrieved, the blastocyst formation rate, and the chromosomal normalcy rate (strongly correlated with age).

④ Use of Special Techniques

IMSI (Intracytoplasmic Morphologically Selected Sperm Injection), assisted hatching, time-lapse imaging culture, etc., are additional items, each costing an extra 3,000 to 8,000 RMB. These techniques are not suitable for everyone; the doctor decides based on embryo condition and history of previous failures.

⑤ Number of Transfers and Freeze Cycles

If the first transfer does not result in pregnancy, subsequent frozen embryo transfers require separate payment for the transfer procedure (approximately 15,000 to 25,000 RMB per cycle) and endometrial preparation medication. Embryo cryopreservation storage costs approximately 3,000 to 6,000 RMB per year. If multiple embryo straws are stored, renewing the storage for several years can become a significant expense.

⑥ Need for Additional Genetic Screening

If one partner carries a single gene disorder or has a chromosomal structural rearrangement, customized PGT-M or PGT-SR probes are required. The customization cost is approximately 15,000 to 30,000 RMB and requires 4 to 6 weeks of preparation time. This cost is not included in the basic PGT-A package.

Module G: Easiest Details to Overlook

4 Easiest Cost Details to Overlook

Many people focus only on "surgery fees" and "medication costs" when budgeting, overlooking the following items:

• Initial Consultation Examination Fees: Basic fertility assessment for both partners, infectious disease screening, chromosome karyotype analysis, etc., totaling approximately 5,000 to 10,000 RMB. If previous medical reports have expired (usually valid for 6-12 months), they need to be redone.
• Cryopreservation Storage Renewal Fees: The initial freezing fee is usually included in the egg retrieval cycle, but renewal fees from the second year onwards must be paid separately. If renewal is not made on time, the embryos may be discarded.
• Hysteroscopy Examination: If there are endometrial polyps, adhesions, or chronic endometritis, a hysteroscopy is needed before the transfer. Examination + surgery costs approximately 8,000 to 15,000 RMB and is not included in the basic package.
• Additional Fee for Male Sperm Retrieval Difficulty: If testicular/epididymal sperm aspiration (TESA/PESA) is required, an additional fee of approximately 8,000 to 12,000 RMB applies. Some male factors are not fully assessed during the initial consultation and are only discovered after the cycle starts, causing budget overruns.

Module H: Common Pitfalls

3 Common Misconceptions in Cost Planning

Based on past cases encountered, the following three situations most often lead to budget loss of control:

• Attracted by "Low-Price Packages," Ignoring Individual Differences: Some agencies or clinics advertise "PGT-A all-inclusive for 98,000 RMB," but a closer look at the terms reveals it excludes medication costs, embryo freezing fees, pre-transfer hysteroscopy, etc. Completing a full cycle often results in actual expenses 40% to 60% higher. As a reputable center, LRC typically provides a detailed fee list rather than a flat-rate package, requiring patients to confirm each item.
• Underestimating Medication Cost Fluctuations: For individuals with poor or high ovarian response, the dosage of stimulation medication may increase by 50% to 100% compared to the initial estimate. Budgeting based on the minimum dosage can lead to unexpected expenses when additional medication is needed later. It is recommended to reserve a 30% flexibility margin in the budget for medication costs.
• Not Accounting for the Cost of "Failure": If the first transfer is unsuccessful, each subsequent frozen embryo transfer costs approximately 15,000 to 25,000 RMB. If there is only one embryo and it does not implant, a new full cycle is required, effectively paying for another complete cycle. It is advisable to reserve at least the cost of one frozen embryo transfer in the budget plan.

Module I: Actual Process and Payment Milestones

Payment Milestones Corresponding to the Process

Understanding what to pay at which stage helps in arranging funds in advance:

The above are direct medical costs, excluding living expenses. It is recommended to have all medical funds prepared before traveling to Thailand, and to set aside an additional 30,000 to 50,000 RMB as an emergency reserve.

Module J: How Time Arrangement Affects Cost

How Time Arrangement Affects Cost

The longer the stay in Thailand, the higher the living costs. However, unreasonable time arrangements can also increase medical expenses:

• Ovarian Stimulation Phase: Typically takes 10-14 days. If follicle growth is slow, it may be extended by 2-4 days, increasing both medication and accommodation costs.
• Embryo Culture and PGT Waiting Period: It takes 5-6 days after egg retrieval to get blastocyst culture results, and PGT screening takes 10-14 days. You can return home to wait or stay in Thailand. If you choose to wait in Thailand for results, you need to budget for 2-3 weeks of accommodation.
• Transfer Timing: If the endometrial condition is not ideal in the current month (e.g., thin endometrium, poor morphology, fluid), the doctor may recommend canceling the cycle and transferring at a later date. This means an additional trip to Thailand, increasing costs for flights, accommodation, and time off work.
• Multiple Transfers: Each frozen embryo transfer cycle requires a 10-14 day stay in Thailand. If the first transfer is unsuccessful, the cost of subsequent transfers includes not only medical fees but also repeated travel expenses.

Module Q: Frequently Asked Questions

5 High-Frequency Questions About LRC Costs

Below are questions repeatedly asked in actual consultations, answered uniformly:

Q1: Are LRC costs more expensive or cheaper than other centers in Thailand?

LRC is positioned in the mid-to-upper range. Its laboratory equipment and embryo culture technology are at the forefront. PGT screening uses NGS technology, and fees are similar to other top-tier Bangkok fertility centers (such as Jetanin, BNH, etc.), slightly higher than some smaller clinics. However, the cost difference mainly reflects laboratory standards and embryologist experience. It's not simply "more expensive is better"; it needs to be evaluated based on your own embryo situation and budget.

Q2: If AMH is very low, will the cost be particularly high?

Low AMH means the number of eggs retrieved may be lower, potentially increasing stimulation medication costs (due to higher dosage needed), but PGT screening costs may be lower (because fewer embryos are submitted for testing). The total cost is not necessarily higher, but the average cost per embryo increases. For individuals with AMH < 0.5, multiple egg retrieval cycles may be needed to accumulate embryos, significantly increasing the total cost. In such cases, it is advisable to complete a full evaluation first before deciding on a cumulative cycle plan.

Q3: Does LRC accept credit card payments? Do I need to exchange currency?

LRC accepts credit cards (Visa/Mastercard) and bank transfers. Some items accept Thai Baht cash. It is recommended to bring a credit card with no foreign transaction fees and also prepare some Thai Baht cash for living expenses. Large medical payments by card usually incur a 1% to 2% handling fee; inquire in advance.

Q4: If there are no normal embryos after PGT screening, how are the costs handled?

The PGT screening fee is charged based on the number of embryos submitted for testing and is non-refundable regardless of the outcome. Blastocyst culture and biopsy fees have also been incurred. This is a risk point to understand in advance. For individuals of advanced age or at high risk of chromosomal abnormalities, it is advisable to thoroughly discuss the expected euploidy rate with the doctor before starting the cycle, preparing both mentally and financially.

Q5: Is there a way to reduce costs?

Without compromising medical quality, you can control expenses by: choosing domestic stimulation medications (if applicable), reducing unnecessary add-on techniques, opting for cost-effective accommodation while waiting for results in Thailand, and taking advantage of exchange rate fluctuations to exchange currency early. However, do not cut corners on necessary examinations or screening items to save money, as this could lead to greater losses later.

Module N: Special Circumstances Handling

Cost Changes Under Special Circumstances

The following situations can lead to costs significantly different from the standard plan:

• Egg/Sperm Donation: LRC collaborates with legal egg and sperm banks in Thailand. Using donor eggs (requires waiting for a match, approximately 3-12 months) increases costs by 80,000 to 120,000 RMB; donor sperm increases costs by 20,000 to 40,000 RMB. Donor egg cycles typically use fresh egg transfers, and the process and cost structure differ from autologous cycles.
• Repeated Implantation Failure (RIF): If there have been ≥3 previous failed transfers, the doctor may recommend an ERA endometrial receptivity test, comprehensive immune testing, or uterine microbiome testing. An ERA test costs approximately 8,000 to 12,000 RMB; immune testing costs about 5,000 to 10,000 RMB. These additional tests can help identify the cause but will increase the total cost.
• Need for Third-Party Assistance: Thai law prohibits commercial surrogacy. If third-party assistance is medically necessary, you must travel to a country where it is legal. This cost falls outside LRC's regular services and is beyond the scope of this discussion.
• Male Azoospermia: Sperm retrieval via micro-TESE is required, with a surgical fee of approximately 12,000 to 18,000 RMB, plus sperm freezing costs, adding an extra 15,000 to 25,000 RMB. It is recommended that the male partner complete a semen analysis during the initial consultation, rather than discovering the issue on the day of egg retrieval.

Module R: Practitioner's Observation

Practitioner's Observation: The Three Most Important Things in Cost Planning

After handling hundreds of IVF cases in Thailand, three points have been repeatedly proven to be key to budget management:

• Do Not Budget Without Complete Information: At a minimum, you need the basic fertility assessment reports for both partners (AMH, FSH, antral follicle count, semen analysis) to make a reliable cost estimate. Many people ask "how much will it cost in total" without this data, and the answer is essentially an estimate with limited reference value.
• Set Aside a "Risk Reserve": No matter how detailed the budget, it is very common for actual expenses to be 10% to 20% higher than expected. This money is not for regular expenses but to cover unexpected situations like increased medication dosage, need for additional tests, or an extra transfer cycle. Without this reserve, you can find yourself in a very difficult position midway.
• Consider "Success Rate" and "Cost" Together: Simply comparing prices is not very meaningful. A center's laboratory standards, embryologist experience, and PGT technical stability directly impact embryo survival rates and screening accuracy. Choosing a substandard facility to save money, leading to embryo loss or misdiagnosis, can result in remedial costs far exceeding the savings. LRC has mature technical expertise in embryo culture and PGT, which provides a reasonable basis for its pricing.